Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Cardiff

Showing results (121-130 of 182) with videos related to

Pageof 19
Sort By:
Cancer Research|May 31, 2002
Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesisMinjung J Kim, Rajula Bhatia-Gaur, Whitney A Banach-Petrosky, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Nonlinear progression during the occult transition establishes cancer lethalityJoshua D Ginzel, Henry Chapman, Joelle E Sills, et al.
Nature|August 13, 2015
PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumoursShany Koren, Linsey Reavie, Joana Pinto Couto, et al.
Disease Models & Mechanisms|March 19, 2025
Nonlinear progression during the occult transition establishes cancer lethalityJoshua D Ginzel, Henry Chapman, Joelle E Sills, et al.
BMC Cancer|December 7, 2006
Heterogeneity of mammary lesions represent molecular differencesRuria Namba, Jeannie E Maglione, Ryan R Davis, et al.
Molecular Cancer Research : MCR|September 24, 2004
Mice expressing SV40 T antigen directed by the intestinal trefoil factor promoter develop tumors resembling human small cell carcinoma of the colonJames R Gum, James W Hicks, Suzanne C Crawley, et al.
Plos Biology|September 30, 2004
Developmental context determines latency of MYC-induced tumorigenesisShelly Beer, Anders Zetterberg, Rebecca A Ihrie, et al.
Cancer Cell|March 7, 2003
PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanismsDaniel J Freeman, Andrew G Li, Gang Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situRuria Namba, Lawrence J T Young, Craig K Abbey, et al.
Oncogene|June 19, 2003
Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiationBrian Bierie, Masahiro Nozawa, Jean-Pierre Renou, et al.
Pageof 19

Showing results (121-130 of 182) with videos related to

Sort By:
Pageof 19
Cancer Research|May 31, 2002
Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesisMinjung J Kim, Rajula Bhatia-Gaur, Whitney A Banach-Petrosky, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Nonlinear progression during the occult transition establishes cancer lethalityJoshua D Ginzel, Henry Chapman, Joelle E Sills, et al.
Nature|August 13, 2015
PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumoursShany Koren, Linsey Reavie, Joana Pinto Couto, et al.
Disease Models & Mechanisms|March 19, 2025
Nonlinear progression during the occult transition establishes cancer lethalityJoshua D Ginzel, Henry Chapman, Joelle E Sills, et al.
BMC Cancer|December 7, 2006
Heterogeneity of mammary lesions represent molecular differencesRuria Namba, Jeannie E Maglione, Ryan R Davis, et al.
Molecular Cancer Research : MCR|September 24, 2004
Mice expressing SV40 T antigen directed by the intestinal trefoil factor promoter develop tumors resembling human small cell carcinoma of the colonJames R Gum, James W Hicks, Suzanne C Crawley, et al.
Plos Biology|September 30, 2004
Developmental context determines latency of MYC-induced tumorigenesisShelly Beer, Anders Zetterberg, Rebecca A Ihrie, et al.
Cancer Cell|March 7, 2003
PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanismsDaniel J Freeman, Andrew G Li, Gang Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situRuria Namba, Lawrence J T Young, Craig K Abbey, et al.
Oncogene|June 19, 2003
Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiationBrian Bierie, Masahiro Nozawa, Jean-Pierre Renou, et al.
Pageof 19